The Impact of Administration Strategy of Ticagrelor on Its Pharmacokinetics and Pharmacodynamics in Patients With Unstable Angina Pectoris - a Randomized, Single-center, Open-label Pilot Study

Trial Profile

The Impact of Administration Strategy of Ticagrelor on Its Pharmacokinetics and Pharmacodynamics in Patients With Unstable Angina Pectoris - a Randomized, Single-center, Open-label Pilot Study

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Oct 2016

At a glance

  • Drugs Ticagrelor (Primary)
  • Indications Angina pectoris
  • Focus Pharmacokinetics
  • Most Recent Events

    • 18 Oct 2016 Status changed from active, no longer recruiting to completed.
    • 21 Aug 2016 Planned number of patients changed from 30 to 49.
    • 21 Aug 2016 Planned End Date changed from 1 Jun 2016 to 1 Sep 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top